ARCHIVES

Report: Rising Treatment Costs Due to 340B Discounts

This article is from The Cancer Letter archive.

Vol. 40 No. 20 | May 16, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Issues Final Rules On Patient Access To Investigational Drugs

September 11, 2009

Politics, Short Tempers, Grievances Dominate NIH Panel On Unconventional Medical Practices

September 25, 1992

In Brief: Hazleton Acquires Prime Labs, Primate Importer; Cullen UCLA Deputy Director

July 30, 1976

Scientists Lose Credibility When “Fire Alarm” Pulled Too Early, ACS’s Brawley Says.

August 1, 2008

In Brief: Control Grant Review committee Out Of Grants Division Provisional Training Announcement Due

October 10, 1975

Funding Opportunities: NCI extends Deadline for Three RFAs

July 9, 1999